Department of Pharmaceutics, St. Peter's Institute of Pharmaceutical Sciences, Hanamkonda, Warangal, Andhra Pradesh, India.
J Microencapsul. 2013;30(2):161-72. doi: 10.3109/02652048.2012.714408. Epub 2012 Aug 15.
Self-nanoemulsifying drug delivery systems (SNEDDSs) offer potential as suitable carriers for improved oral delivery of poorly soluble and low bioavailable drugs. To derive self-nanoemulsifying powders (SNEPs), the optimized Z-SNEDDS formulation was adsorbed onto different carriers and based on micromeritics the formulation loaded onto neusilin US2 (SNEP-N) was selected for further characterization. The solid-state characterization (scanning electron microscopy, differential scanning calorimetry and powder X-ray diffraction) studies unravel the transformation of native crystalline state to amorphous and/or molecular state. The higher predictive effective permeability coefficient and fraction absorbed in humans extrapolated from in situ single-pass intestinal absorption study data in rats provide an insight on the potential of SNEPs for augment in absorption across gastrointestinal barrier. Overall a 3.5-fold enhancement in the extent of absorption of zaleplon from SNEP-N formulation proves the feasibility of SNEPs formulation for improved oral delivery of zaleplon.
自微乳药物传递系统(SNEDDS)为改善难溶性和生物利用度低的药物的口服递送提供了潜在的合适载体。为了获得自微乳粉末(SNEPs),将优化的 Z-SNEDDS 制剂吸附到不同的载体上,并根据微粉学特性,选择负载到 Neusilin US2 上的制剂(SNEP-N)进行进一步的特性描述。固态特性研究(扫描电子显微镜、差示扫描量热法和粉末 X 射线衍射)揭示了从天然结晶状态向无定形和/或分子状态的转变。从大鼠在体单向肠吸收研究数据中推算出的更高的预测有效渗透系数和人吸收分数,为 SNEPs 增加跨胃肠道屏障吸收的潜力提供了深入了解。Zaleplon 从 SNEP-N 制剂中的吸收程度提高了 3.5 倍,证明了 SNEPs 制剂对于改善 zaleplon 的口服递送的可行性。